Latest filing published 10 Mar 2025 for Quantum BioPharma Ltd.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Michael Shawn Zapolin discloses dealings in 2 companies, chiefly FSD Pharma Inc. and Quantum BioPharma Ltd. Altogether 2 filings, all relating to 29 June 2023.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 10 March 2025: a transaction, in Quantum BioPharma Ltd. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations